We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+3.71%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$76.9B
AUM Growth
+$11.3B
Cap. Flow
+$9.16B
Cap. Flow %
11.92%
Top 10 Hldgs %
31.81%
Holding
7,054
New
709
Increased
2,754
Reduced
2,613
Closed
569

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$376M
2
AAPL icon
Apple
AAPL
+$264M
3
STJ
St Jude Medical
STJ
+$263M
4
MSFT icon
Microsoft
MSFT
+$260M
5
BABA icon
Alibaba
BABA
+$172M

Sector Composition

Rank Sector Weight
1 Technology 5.56%
2 Healthcare 4.73%
3 Financials 4.3%
4 Consumer Discretionary 3.31%
5 Energy 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSIR
5501
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$9K ﹤0.01%
1,859
-33,162
-95% -$179K
AGIO icon
5502
Agios Pharmaceuticals
AGIO
$1.79B
$8K ﹤0.01%
189
-3,704
-95% -$183K
CHI
5503
Calamos Convertible Opportunities and Income Fund
CHI
$1.01B
$8K ﹤0.01%
+800
New +$7.7K
CM icon
5504
PUT
Canadian Imperial Bank of Commerce
CM
$108B
$8K ﹤0.01%
200
-6,400
-97% -$250K
CMC icon
5505
PUT
Commercial Metals
CMC
$7.6B
$8K ﹤0.01%
+500
New +$8.6K
EHC icon
5506
PUT
Encompass Health
EHC
$11B
$8K ﹤0.01%
251
FHN icon
5507
CALL
First Horizon
FHN
$12.2B
$8K ﹤0.01%
600
-1,800
-75% -$24.9K
HBIO icon
5508
Harvard Bioscience
HBIO
$27.5M
$8K ﹤0.01%
+285
New +$9.06K
HEES
5509
DELISTED
H&E Equipment Services
HEES
$8K ﹤0.01%
+434
New +$8.16K
IBRX icon
5510
ImmunityBio
IBRX
$7.51B
$8K ﹤0.01%
1,362
+801
+143% +$6.22K
IYM icon
5511
CALL
iShares US Basic Materials ETF
IYM
$1.12B
$8K ﹤0.01%
+100
New +$7.63K
NEWT icon
5512
NewtekOne
NEWT
$428M
$8K ﹤0.01%
+635
New +$8.03K
NOG icon
5513
CALL
Northern Oil and Gas
NOG
$2.3B
$8K ﹤0.01%
180
-460
-72% -$21.6K
PXLW icon
5514
CALL
Pixelworks
PXLW
$38.2M
$8K ﹤0.01%
375
RSP icon
5515
CALL
Invesco S&P 500 Equal Weight ETF
RSP
$97B
$8K ﹤0.01%
100
-4,700
-98% -$374K
SENEA icon
5516
Seneca Foods Class A
SENEA
$1.12B
$8K ﹤0.01%
239
-1,251
-84% -$41.3K
SNDX icon
5517
Syndax Pharmaceuticals
SNDX
$1.69B
$8K ﹤0.01%
+798
New +$10.9K
TBRG
5518
DELISTED
TruBridge
TBRG
$8K ﹤0.01%
200
-697
-78% -$31.6K
IVAC
5519
DELISTED
Intevac Inc
IVAC
$8K ﹤0.01%
1,400
+910
+186% +$4.51K
DMK
5520
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$8K ﹤0.01%
+41
New +$18.9K
NXGN
5521
CALL
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$8K ﹤0.01%
700
+300
+75% +$4.03K
VIVO
5522
DELISTED
Meridian Bioscience Inc
VIVO
$8K ﹤0.01%
+389
New +$7.63K
BBQ
5523
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
$8K ﹤0.01%
+1,500
New +$8.22K
PGNX
5524
PUT
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$8K ﹤0.01%
1,900
+1,400
+280% +$6.76K
NVTR
5525
DELISTED
Nuvectra Corporation Common Stock
NVTR
$8K ﹤0.01%
1,154
-24,383
-95% -$194K

Similar funds

Barclays's Q2 2016 Portfolio in Review

As of Q2 2016, Barclays held 7,054 positions worth $76.9B, up 17% from $65.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Barclays deployed $9.16B of net new capital in Q2 2016, opening 709 new positions and adding to 2,754 existing holdings. Its largest new stake was S&P Global: 236,625 shares worth $25.4M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.

  • Barclays's largest Q2 2016 buy was S&P Global: 236,625 shares worth $25.4M.
  • Barclays added most to McDonald's in Q2 2016, an estimated $376M increase.
  • Barclays's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
  • Barclays fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $261M.
  • Barclays's ten largest holdings make up 32% of its $76.9B portfolio in Q2 2016.
  • Barclays opened 709 new positions and closed 569 in Q2 2016.
  • Barclays's portfolio value rose 17% quarter-over-quarter to $76.9B.

Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.